Hologic, Inc. (HOLX) は上場企業です ヘルスケア セクターの Medical - Instruments & Supplies 業界で事業展開. 本社所在地は Marlborough, MA, アメリカ. 現CEOは Stephen MacMillan.
HOLX を有する IPO日 1990-03-01, 7,063 名の正社員, に上場 NASDAQ Global Select, 時価総額 $16.97B.
Hologic, Inc. is a global medical technology company that develops, manufactures, and supplies diagnostic products, medical imaging systems, and surgical solutions focused on women's health. Operating through four business segments—Diagnostics, Breast Health, GYN Surgical, and Skeletal Health—the company offers a comprehensive portfolio including molecular diagnostic assays for infectious disease detection, advanced breast imaging and biopsy systems, minimally invasive gynecological surgical devices, and orthopedic imaging solutions. Hologic serves healthcare providers across the United States, Europe, Asia-Pacific, and international markets through direct sales forces and independent distributors. Founded in 1985 and headquartered in Marlborough, Massachusetts, the company is committed to enabling early detection and treatment across the continuum of women's health.
